IL10 and colitis: Interestingly, in our previous study, intrarectal injection of tranostat improved the symptoms and pathology of DSS-induced colitis mice, potentially through the increased expression of HO-1 by tranostat which induced the expression of the anti-inflammatory factor IL-10 (30, 31).